Items Tagged with 'Drug Pipeline Alert'


FDA Approves Ranbaxy's Generic Claritin

Ohm Laboratories, a wholly owned subsidiary of Ranbaxy Laboratories, announced it has received FDA approval to manufacture and commercialize its generic loratadine orally disintegrating tablets, 10 mg.

Read More

GSK Announces FDA Approval of Antibacterial Ointment

GlaxoSmithKline (GSK) announced that the FDA has approved its antibacterial Altabax for the topical treatment of impetigo due to susceptible strains of Staphylococcus aureus or Streptococcus pyogenes, the two most common types of bacteria in this kind of infection.

Read More

Roche Presents Efficacy and Safety Data on Mircera in CKD

Roche presented data analyses from a large registration trial program to provide efficacy and safety information on Mircera for the treatment of renal anemia associated with chronic kidney disease (CKD) at the National Kidney Foundation Spring Clinical Meeting.

Read More

Idenix Reports Results From Two Hepatitis C Studies

Idenix Pharmaceuticals has announced results from two Phase IIb studies of the novel combination of valopicitabine and Pegasys in both treatment-naive and treatment-experienced patients infected with the genotype-1 strain of the hepatitis C virus (HCV).

Read More